Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.72
+0.38500.85%
Volume:2.13M
Turnover:97.82M
Market Cap:202.20B
PE:11.42
High:46.16
Open:45.82
Low:45.57
Close:45.33
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:1.34
T/O Rate:0.07%
Dividend:1.72
Dividend Rate:3.77%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.21
PE(LYR):12.63

Loading ...

Novo Nordisk Wins CHMP Backing for High-Dose Wegovy Single-Dose Pen in EU

TIPRANKS
·
May 23

Novo Nordisk Expands Obesity Reach With AMAZE 3 Sleep Apnoea Trial

TIPRANKS
·
May 23

Novo Nordisk A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
May 23

BUZZ-U.S. STOCKS ON THE MOVE-IMAX, Novo Nordisk, PC makers

Reuters
·
May 22

BRIEF-EMA's CHMP Recommends Extension To Marketing Authorisation For Wegovy

Reuters
·
May 22

European medicines regulator recommends approval for Novo's Wegovy pill

Reuters
·
May 22

Market Chatter: Novo Nordisk, Eli Lilly Weight-Loss Drugs Show Promise in Slowing, Preventing Cancer

MT Newswires Live
·
May 22

Studies suggest Ozempic, Mounjaro may slow tumor progression, WSJ reports

TIPRANKS
·
May 22

Weight Loss Drugs Linked to Potential Cancer Risk Reduction, Boosting Prospects for Novo Nordisk and Eli Lilly

Deep News
·
May 22

Popular Weight Loss Drugs May Have Surprising Side Effect: Stalling Cancer -- WSJ

Dow Jones
·
May 22

Canada and India now have generic Wegovy. Here's why the U.S. doesn't.

Dow Jones
·
May 22

European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading

MT Newswires Live
·
May 21

Mixed options sentiment in Novo Nordisk with shares down 2.12%

TIPRANKS
·
May 21

Live Longer and Better. Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 21

Singapore Court of Appeal Notes No Finding of Fraud Against KBP or Dr. Huang; Dispute with Novo Nordisk Undergoing Arbitration Proceedings

prnewswire
·
May 21

Novo Nordisk A/S Stock Rises Wednesday, Underperforms Market

Dow Jones
·
May 21

Deutsche Bank Remains a Hold on Novo Nordisk (0QIU)

TIPRANKS
·
May 20

Wegovy Liver Data Broadens Semaglutide Story For Novo Nordisk Investors

Simply Wall St.
·
May 20

Novo Nordisk Advances New Cagrilintide Study in the Race for Obesity Leadership

TIPRANKS
·
May 20

Novo Nordisk’s AMAZE 2 Trial: A New Weight-Loss Shot Targets Growth Beyond Semaglutide

TIPRANKS
·
May 20